RxDoctor Payments Data

A Michael Borkon, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · York, PANPI 1336190602

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,334 of the $1,956 with a category attached, or 68.2%. 12 manufacturers reported payments, led by Abbott at 42.8% of the total. Reporting peaked in 2022 at $844 and has fallen 65.4% since, to $292 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in PA, where the typical reported total is $5,177.

$1,956in general payments, 2019–2025

Across 29 payments — averaging $67.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$838
  • Edwards Lifesciences$327
  • La Jolla Pharmaceutical Company$165
  • Atricure, Inc.$140
  • Xvivo Perfusion Inc.$139
  • W. L. Gore & Associates, Inc.$131
  • plus $216 from 6 others
$21,216in research payments, 2019–2025

Across 15 payments — averaging $1414.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$21K

What the payments were for

  • Travel & lodging$62232%
  • Food & beverage$1,33468%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,956 in reported general payments places this provider in the 35th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$34,115
Medicare patients
57
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in York

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →